Yield Theory

Stock research

Amgen Inc. AMGN

Amgen is one of the largest biotechnology companies, with therapies spanning cardiovascular disease, oncology, and inflammation. It is also advancing candidates in the fast-growing obesity-treatment market.
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

Ticker
AMGN
Exchange
NASDAQ
Sector
Health
Founded
1980

What moves AMGN

Amgen Inc. sits in Health Care. Pharmaceuticals, biotech, medical devices, and managed care — defensive demand paired with binary drug and regulatory catalysts. The forces that matter most for the sector — and therefore for AMGN — are:

  • Drug approvals and clinical-trial readouts
  • Medicare and drug-pricing policy
  • Demographics and an aging population
  • GLP-1 and obesity-drug demand

Congressional trading in AMGN

No matched AMGN transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

The profile is free

AMGN research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.

Get this month’s call for $15

How Yield Theory covers AMGN

AMGN intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US markets

AMGN — frequently asked questions

What sector is AMGN in?

Amgen Inc. is classified in the Health Care sector and trades on the NASDAQ.

Do members of Congress trade AMGN?

The current verified House Clerk snapshot contains no matched AMGN transaction rows. That is not proof that no lawmaker has ever traded the security.

Is AMGN a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

Where is Amgen Inc. headquartered?

Amgen Inc. is headquartered in Thousand Oaks, California and was founded in 1980.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

See whether the AMGN thesis still holds.

This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included